BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 83728)

  • 1. Detection of non-HLA antibodies in bone marrow transplant recipients.
    Opelz G; Walker J; Gale RP
    Transplant Proc; 1978 Dec; 10(4):963-4. PubMed ID: 83728
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-HLA lymphocytotoxic antibodies during GVHD after bone marrow transplantation (BMT).
    Gluckman E; Andersen E; Lepage V; Dausset J
    Transplant Proc; 1977 Mar; 9(1):761-3. PubMed ID: 17200
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunobiology of transplant rejection.
    Häyry P
    Ann Clin Res; 1981; 13(4-5):172-98. PubMed ID: 7039479
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunology of bone marrow grafts].
    Dreyfus F
    Ann Med Interne (Paris); 1986; 137(8):617-20. PubMed ID: 3551717
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA and bone marrow transplantation.
    Bach FH
    Prog Clin Biol Res; 1984; 149():257-70. PubMed ID: 6204340
    [No Abstract]   [Full Text] [Related]  

  • 6. The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
    Gajewski J; Gjertson D; Cecka M; Tonai R; Przepiorka D; Hunt L; Giralt S; Chan KW; Feig S; Territo M; Andersson B; van Besien K; Khouri I; Fischer H; Babbitt L; Ippolitti C; Schiller G; Lill M; Warkentin D; Neumann J; Petz L; Terasaki P; Champlin R
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):76-82. PubMed ID: 9267667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of selective donor T-cell depletion on the graft-versus-leukemia reaction in allogeneic marrow transplantation.
    OKunewick J; Kociban D; Machen L; Buffo M
    Transplant Proc; 1992 Dec; 24(6):2998-9. PubMed ID: 1361270
    [No Abstract]   [Full Text] [Related]  

  • 9. Major and minor histocompatibility systems in man and their importance in bone marrow transplantation.
    van Rood JJ; van Leeuwen A
    Transplant Proc; 1976 Sep; 8(3):429-36. PubMed ID: 62433
    [No Abstract]   [Full Text] [Related]  

  • 10. The human histocompatibility complex: a review for the hematologist.
    Miller WV
    Prog Hematol; 1977; 10():173-91. PubMed ID: 337359
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunorestoration.
    Good RA; Kapoor N
    Symp Fundam Cancer Res; 1986; 38():269-74. PubMed ID: 3529277
    [No Abstract]   [Full Text] [Related]  

  • 13. [Bone marrow transplantation and immunologic reconstitution].
    Piazzon I; Dosne Pasqualini C
    Medicina (B Aires); 1981; 41(2):233-43. PubMed ID: 7024717
    [No Abstract]   [Full Text] [Related]  

  • 14. Major histocompatibility complex influences the development of acute graft-versus-host disease in MHC-matched adult allogeneic bone marrow transplantation.
    Smyth LA; Herrmann RP; Christiansen FT; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1276-8. PubMed ID: 8442111
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone marrow transplantation across major histocompatibility barriers in rabbits. I. A positive role for graft-versus-host reactivity in engraftment.
    Adler LT; Annaratone LJ; LeBeau MM
    Bone Marrow Transplant; 1990 Jan; 5(1):51-6. PubMed ID: 2297590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different biology and pathology of minor alloantigen-specific cytotoxic and proliferative T cells.
    van Els C; Bakker A; van Rood J; Goulmy E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):429-30. PubMed ID: 1990577
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow transplantation across major histocompatability barriers in mice. III. Treatment of donor grafts with monoclonal antibodies directed against Lyt determinants.
    Vallera DA; Soderling CC; Kersey JH
    J Immunol; 1982 Feb; 128(2):871-5. PubMed ID: 6172513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 19. The problems and practice of bone marrow transplantation in man: the severe combined immunodeficiency syndrome as the ideal model.
    Levey RH
    Transplant Proc; 1972 Dec; 4(4):565-6. PubMed ID: 4405148
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study.
    Filipovich AH; McGlave P; Ramsay NK; Goldstein G; Kersey JH
    J Clin Immunol; 1982 Jul; 2(3 Suppl):154S-157S. PubMed ID: 6752174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.